Moghimi S M, Simberg D
School of Medicine, Pharmacy and Health, Durham University, Queen's Campus, Stockton-on-Tees, TS17 6BH, United Kingdom.
Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, 12850 East Montview Blvd., Aurora, CO, 80045, USA.
Nano Today. 2017 Aug;15:8-10. doi: 10.1016/j.nantod.2017.03.001. Epub 2017 Apr 12.
The complement system is an important component of the innate immune system, which contributes to non-specific host defence. Particulate matters, such as invading pathogens and nanomedicines, in the blood may activate the complement system through classical, lectin and alternative pathways. Complement activation can aid recognition and clearance of particulate matters by immune cells, but uncontrolled complement activation can inflict damage and be life threatening. Plasma proteins on adsorption to surfaces of nanoparticles also play a significant role in complement activation and particularly through the alternative pathway. This process is continuous and changeable in vivo; protein-complement complexes are formed on the nanoparticle surface and then released and the cycle repeats on further plasma protein deposition. This complement activation turnover poses a challenge for design of immune-safe nanomedicines.
补体系统是固有免疫系统的重要组成部分,有助于非特异性宿主防御。血液中的颗粒物,如入侵病原体和纳米药物,可通过经典途径、凝集素途径和替代途径激活补体系统。补体激活有助于免疫细胞识别和清除颗粒物,但不受控制的补体激活会造成损害并危及生命。血浆蛋白吸附到纳米颗粒表面时,在补体激活中也起重要作用,尤其是通过替代途径。这一过程在体内是持续且可变的;蛋白质-补体复合物在纳米颗粒表面形成,然后释放,随着血浆蛋白进一步沉积,循环重复进行。这种补体激活周转对免疫安全纳米药物的设计构成了挑战。